China: Vaccine diplomacy fails: Sinovac, CNBG
-US breakthrough, moderna triple production-
“Nikkei”:
The following article was posted on April 30th.
Moderna to more than triple production
Responding to increasing demand for vaccines
Next year, production will increase to 3 billion times
China’s blunder:
China was initially likely to dominate the world in vaccine diplomacy.
However, it is completely in line with the US turnaround.
This is a natural result, as it is not as good as the United States in terms of comprehensive scientific power.
Fatal flaw in made in China:
The Chinese vaccine has the fatal flaw that the results of the clinical trial will not be announced.
With this
Even if you can inoculate forcibly in China
When it comes to inoculation in other countries
It is unavoidable to be shy.
“The Epoch Times”:
On April 30, China’s vaccine diplomacy declined.
The United States has published an article entitled “Investigating the Emanationism from the Wuhan Institute of Veterinary Medicine.”
China’s vaccine diplomacy is declining all over the world.
Several media outlets reported.
ASEAN Post:
The April 6, 2021 article reports:
China’s vaccine development and donation policy
There were great expectations, but
At least in Southeast Asia, there have been no significant results.
Sinovac Biotech Vaccine:
Vaccine made by China Biotechnology (CNBG):
The effectiveness of the two companies’ products has not been clearly demonstrated.
It is thought that the cause of the decline is that the data of late-stage clinical trials are rarely published.
Recent research:
The new Chinese-made coronavirus infection vaccine has proven to be less effective than Western-made vaccines.
Reuters:
In Brazil, two weeks have passed since the second vaccination.
A Brazilian research institute conducted a survey of clinical trials.
The effectiveness of the Sinovac Biotech vaccine was announced to be 50.7%.
Efficacy of Chinese vaccine:
The effectiveness of Chinese vaccines is in the 50% range.
The effectiveness of Western vaccines is in the 90% range.
Few countries want Chinese vaccines.
This difference is clearly a difference in comprehensive scientific power.
Toshiyoshi Katsumata: World View
http://hisayoshi-katsumata-worldview.com/archives/26246328.html